Cardio
The Hereditary Cardio Panel uses Next Generation Sequencing technology to examine 62 genes associated with an increased risk for cardiovascular disease. This test includes well-established disease genes and each of the conditions tested for is considered clinically actionable.
Selected genes were identified based on relevant testing guidelines, curated gene reviews for clinical validity, variant databases (ClinGen, OMIM, HGMD), recent literature, and customer requests.
